MORE►
BioNTX
BioNTX CEO Gina Ford [Photo: LinkedIn]
BioNTX Names Former Women in Bio Leader as Its New CEO
by Sandra Engelland | Mar 6, 2026
Gina Ford will concentrate on boosting industry alignment, increasing the region’s national visibility, and charting a clear course to speed innovation, attract investment and improve long-term competitiveness in the life sciences sector across North Texas, BioNTX said. She replaces Kathleen Otto Rosenblum, who's retiring from the position.
by Sandra Engelland |
Dec 18, 2025
Eight North Texas startups were honored as 2025 BioNTX Rising Stars, in a program designed to elevate emerging companies by providing visibility, credibility, and direct access to investors, industry leaders, and strategic partners.
MORE►
by Lance Murray |
Oct 8, 2025
The partnership establishes a cross-continental bridge between India and North Texas to support "clinical research, translational science, and long-term global impact," BioNTX said.
MORE►
by Glenn Hunter |
Sep 24, 2025
At Dallas’ iC3 Summit, leaders from Texas and across the U.S. pointed to AI, new state initiatives like Proposition 14, and potential federal reforms as keys to speeding innovation and keeping America competitive in life sciences.
MORE►
New this year, the North Texas biotech and healthcare innovation group is inviting entries from institutions in Arkansas, Louisiana, New Mexico, Oklahoma, and Tennessee.
BioNTX Expands University Tech Transfer Showcase to Six-State Region
by Sandra Engelland | Jul 15, 2025
New this year, the North Texas biotech and healthcare innovation group is inviting entries from institutions in Arkansas, Louisiana, New Mexico, Oklahoma, and Tennessee.
MORE►
by Quincy Preston |
Apr 24, 2025
Dallas biotech GenrAb is developing an antibody therapy that aims to protect brain cells under stress—the kind of damage that leads to disability in diseases like MS and ALS. The therapy, found in the spinal fluid of real patients, is now showing promise in animal models and moving toward human trials.
MORE►
by David Seeley |
Feb 12, 2025
Advanced Therapies Week 2025—a conference focused on the latest innovations in cell and gene therapies, regenerative medicine, and other biotechnologies—attracted industry leaders, researchers, and visionaries to Dallas' Kay Bailey Hutchison Convention Center in late January. Organized by London-based Phacilitate, the 4-day conference acted as a "collaborative hub" showcasing the intersection of cutting-edge science, transformative healthcare solutions, and dynamic regional collaboration.
MORE►
by Lance Murray |
Oct 2, 2024
Renibus CEO Jeff Keyser will be acknowledged as the award recipient at the 10th Annual iC³ Life Science & Healthcare Innovation Summit on Thursday, the first day of the Oct. 3-4 summit at the Loews Arlington Hotel & Convention Center.
MORE►
The 2024 BioNTX iC3 Summit will be held Oct. 3-4 at the new Loews Arlington Convention Center in Arlington, which is connected to the Loews Arlington Hotel in the heart of the city's Entertainment District. [Image: Loews Arlington Hotel]
BioNTX Unveils 2024 Rising Stars: 8 Innovative North Texas Companies Shaping Life Sciences
by Lance Murray | Sep 9, 2024
The innovators will be recognized at the 10th Annual BioNTX iC³ Life Science & Healthcare Innovation Summit. The signature event is set for October 3-4 at the new Loews Arlington Convention Center in Arlington.
MORE►
by Lance Murray |
Jun 17, 2024
The 2024 iC3 Summit, hosted by nonprofit BioNTX, is set to welcome over 1,000 industry professionals, researchers, entrepreneurs, and investors for its largest gathering yet. The event's formula—Innovation = Capital × Collaboration × Commercialization,—underscores its mission to drive breakthroughs through strategic partnerships and investments.
The 2024 iC3 Summit, hosted by nonprofit BioNTX, is set to welcome over 1,000 industry professionals, researchers, entrepreneurs, and investors for its largest gathering yet. The event's formula—Innovation = Capital × Collaboration × Commercialization—underscores its mission to drive breakthroughs through strategic partnerships and investments.
MORE►
by David Seeley |
Nov 14, 2023
GEW North Texas—which kicked off Monday and runs through Sunday November 19—is part of Global Entrepreneurship Week, held in cities worldwide one week each November. The movement aims to inspire entrepreneurs around the globe while fostering connections and increasing collaboration within their ecosystems.
MORE►
by Dallas Innovates | Staff Report |
Nov 3, 2023
BioNTX, a leading nonprofit bioscience and healthcare innovation organization in North Texas, has appointed Jon Weidanz to its board of directors. Weidanz brings extensive experience as an immunology researcher, academic leader, biotech entrepreneur, and founder....
MORE►
Form Bio, named as one of eight Rising Stars to be honored at iC3 2023, announced its launch at the last year's summit. [Photo: John Davidson/Form Bio]
BioNTX iC3 Summit to Fuel North Texas Life Science Ecosystem, Honor 8 Rising Stars
by Quincy Preston | Sep 14, 2023
The North Texas bioscience organization, a driving force for growth in the regional ecosystem, will convene leaders at its flagship conference to catalyze industry opportunities, spotlight emerging companies, and make connections.
See who made this year's Rising Stars list—and how you can attend the summit.
See who made this year's Rising Stars list—and how you can attend the summit.
MORE►
by Lance Murray |
Jun 14, 2023
The alliance's first event will be held June 22 in a bid to champion a next-generation, industry-led workforce partnership for North Texas. The alliance seeks to bring together industry trade and manufacturing ecosystems, the organizations said—and it will be working with Dallas College and other partner institutions to help make it happen.
MORE►
by Lance Murray |
Feb 13, 2023
The new two-story lab and office building will offer "the first institutional-quality space" in the DFW market, according to marketing materials.
MORE►
by Quincy Preston and David Seeley |
Dec 19, 2022
Co-founders Paul Stewart and Frank Murdock started up SkinStasis Skin Care earlier this year to meet "a big unmet need" in the cold sore/herpes virus field, where they say there's been "no real new pharmaceutical development" for over 20 years.
Working out of BioLabs at Pegasus Park, they teamed up with Irving's Cosmetic Laboratories to launch NextLeap—which uses tranexamic acid to shorten the time to recovery of normal appearance to as little as 24 to 48 hours, the co-founders say.
Working out of BioLabs at Pegasus Park, they teamed up with Irving's Cosmetic Laboratories to launch NextLeap—which uses tranexamic acid to shorten the time to recovery of normal appearance to as little as 24 to 48 hours, the co-founders say.
MORE►
